Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 364.02 USD -0.09% Market Closed
Market Cap: 139.2B USD

Stryker Corp
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Stryker Corp
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Stryker Corp
NYSE:SYK
Other Current Liabilities
$7.4B
CAGR 3-Years
145%
CAGR 5-Years
73%
CAGR 10-Years
38%
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$330m
CAGR 3-Years
28%
CAGR 5-Years
18%
CAGR 10-Years
27%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.5B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
-1%
IDEXX Laboratories Inc
NASDAQ:IDXX
Other Current Liabilities
$124.9m
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$570.5m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
10%
No Stocks Found

Stryker Corp
Glance View

Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.

SYK Intrinsic Value
326.38 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

What is Stryker Corp's Other Current Liabilities?
Other Current Liabilities
7.4B USD

Based on the financial report for Sep 30, 2025, Stryker Corp's Other Current Liabilities amounts to 7.4B USD.

What is Stryker Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
38%

Over the last year, the Other Current Liabilities growth was 961%. The average annual Other Current Liabilities growth rates for Stryker Corp have been 145% over the past three years , 73% over the past five years , and 38% over the past ten years .

Back to Top